The Schall Law Firm Encourages Shareholder Involvement in Securities Fraud Lawsuit Against Applied Therapeutics Inc.

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Applied Therapeutics, Inc.

Overview

LOS ANGELES, CA / ACCESSWIRE / December 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between January 3

Leave a Reply